Ticker Launch
Sign inTry it free

SPAC · Merger completed

Mountain Crest Acquisition Corp II

Business combination with Better Therapeutics OpCo, Inc.

Mountain Crest Acquisition Corp II is a blank-check company (SPAC) that raised $50M in its initial public offering on Jan 11, 2021, listing on Nasdaq Capital Market. It completed its business combination with Better Therapeutics OpCo, Inc. on Oct 28, 2021; the combined company is Better Therapeutics, Inc. (BTTX). Chardan led the IPO. Loeb & Loeb advised the SPAC and Reed Smith advised the underwriters on the IPO.

Better Therapeutics OpCo is a prescription digital therapeutics company delivering a behavior-based therapy intended to address the root causes of cardiometabolic diseases. It is the target of a business combination with Mountain Crest Acquisition Corp. II.

Status
Merger completed
IPO date
Jan 11, 2021
IPO size
$50M
IPO exchange
Nasdaq Capital Market
Target
Better Therapeutics OpCo, Inc. (BTX)
Announced
Apr 7, 2021
Closed
Oct 28, 2021
Combined company
Better Therapeutics, Inc. (BTTX)
IPO underwriters
Chardan
SPAC counsel (IPO)
Loeb & Loeb
Underwriters' counsel (IPO)
Reed Smith

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021